2007-10-01
Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: A comparison in 95 patients
Publication
Publication
Journal of Surgical Oncology , Volume 96 - Issue 5 p. 389- 396
Aim: Gastrojejunostomy (GJJ) and duodenal stent placement are the most commonly used palliative treatment modalities for gastric outlet obstruction (GOO). In this retrospective study, we compared GJJ and stent placement with regard to medical effects. Methods: Medical records of 95 patients who had undergone palliative treatment between 1994 and 2006 in a Dutch university hospital, were reviewed. Study outcomes were improvement of food intake, complications, persistent and recurrent symptoms, re-interventions, hospital stay, and survival. Results: Fifty-three patients were referred for duodenal stent placement and 42 patients underwent GJJ. There were no differences in technical and clinical success and the incidence of minor and early major complications and survival. Food intake improved more rapidly after stent placement than GJJ (P = 0.01). The time to late major complications, recurrent obstructive symptoms and re-intervention was significantly shorter after stent placement than GJJ (P = 0.004, 0.002, and 0.004, respectively). Hospital stay was also shorter after stent placement than GJJ (P < 0.001). Conclusion: These findings suggest that stent placement is associated with better short-term outcomes and GJJ with better long-term outcomes. A large randomized controlled trial is however needed to systematically compare stent placement with GJJ with regard to medical effects, quality of life and costs.
Additional Metadata | |
---|---|
, , | |
doi.org/10.1002/jso.20828, hdl.handle.net/1765/35176 | |
Journal of Surgical Oncology | |
Organisation | Erasmus MC: University Medical Center Rotterdam |
Jeurnink, S., Steyerberg, E., van 't Hof, G., van Eijck, C., Kuipers, E., & Siersema, P. (2007). Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: A comparison in 95 patients. Journal of Surgical Oncology, 96(5), 389–396. doi:10.1002/jso.20828 |